NPPA

Effectively the prices of 651 medicines will come down by 6.73%; WPI-linked price rise allowed this fiscal is 12.2%; about 870 formulations fall under the essential category

Sub-committees were formed earlier to categorise medicines, medical devices, disposables, and other health and hygiene products according to how essential they are for healthcare

As per the notification, the ceiling price of one Amoxicillin capsule has been fixed at Rs 2.18; one tablet of Cetirizine at Rs 1.68

The Union health ministry has notified the inclusion of coronary stents in the National List of Essential Medicines, 2022, a move that will help make these life-saving medical devices more affordable. The move is based on the recommendations by an expert committee constituted to review the inclusion of stents in the list based on requirement. The National Pharmaceutical Pricing Authority (NPPA) will now fix the price of coronary stents. On November 6, the Standing National Committee on Medicines (SNCM) had submitted its recommendation for inclusion of coronary stents in the National List of Essential Medicines (NLEM), 2022 in two categories -- Bare Metal Stents (BMS) and Drug Eluting Stents (DES) which include metallic DES and bioresorbable vascular scaffold (VBS)/biodegradable stents. According to minutes of the SNCM meeting, vice chairman Dr Y K Gupta stated that coronary stents were earlier included in NLEM, 2015 through a separate notification based on the recommendations of an

The medicines listed in the NLEM are sold below a price ceiling fixed by the National Pharmaceutical Pricing Authority (NPPA)

Drugs for ailments like chronic kidney disease, some high end antibiotics, anti-virals (anti-infectives), as well as some cancer drugs are likely to be brought under trade margin rationalization first

While the NPPA may allow a 10 per cent rise in prices of NLEM drugs based on WPI this year, the actual price rise could be less, say drug firms

Additional Rs 150 could be service charge; regular market nod expected soon

These include glimepiride tablet of strength 1 mg, with ceiling price at Rs 3.6 per tablet, while that for 2 mg is Rs 5.72 per tablet

The National Pharmaceutical Pricing Authority has fixed ceiling prices of 355 medicines and 882 formulations under the National List of Essential Medicines, 2015, Parliament was informed

Earlier margins were as high as 709% for some devices; revised prices will come into effect from July 20

These are scheduled drugs (or ones that are under price control) and low priced

Drug pricing regulator NPPA undertook necessary steps to ensure availability of life saving essential medicines across the country during the COVID-19 pandemic, the Economic Survey said on Friday. Drug prices in India are regulated to ensure continued availability and affordability of essential medicines with improved access to consumers, it added. "National Pharmaceutical Pricing Authority (NPPA)... has played an active role in addressing the exigencies arising out of COVID-19 pandemic and undertook necessary measures to ensure continued availability of life saving essential medicines throughout the country," the survey said. The regulator invoked extraordinary powers in public interest to ensure that policy enhances access to life saving drugs like Heparin as well as medical oxygen, it added. Timely intervention by NPPA eased the situation of medical oxygen availability throughout the country, especially in distant and far-flung areas. The survey said NPPA also ensured availabil

A price monitoring and resource unit has been set up in Goa under the aegis of the National Pharmaceutical Pricing Authority (NPPA), the government said on Saturday

The present situation of Covid-19 has resulted in increased demand of medical oxygen up to almost four times from 750 MT per day to around 2,800 MT per day, the Ministry said

The NPPA had allowed firms to take a 10 per cent hike for their knee implant products last year

The government on Thursday said aprice monitoring and resource unit (PMRU) has been set up in Karnataka under the aegis of the National Pharmaceutical Pricing Authority (NPPA)

From GoAir suspending international flights to digital payments getting the boost amidst Covid-19 concerns, Business standard brings to you the top headlines of the day

The National Pharmaceutical Pricing Authority (NPPA) invoked the para 32 (ii) of the Drug Price Control Order, 2013 to grant the exemption to the indigenously developed stent

Glenmark had appealed to the pricing regulator in 2016 asking for a differential price for its Digihaler